Lingrui Pharma(SH:600285) Sou Hu Cai Jing·2025-08-25 09:16Group 1 - The core viewpoint of the news highlights the financial performance and stock activity of Lingrui Pharmaceutical as of August 25, 2025, with a closing price of 23.68 yuan, down 1.82% [1] - The company reported total revenue of 2.099 billion yuan for the first half of 2025, representing a year-on-year growth of 10.14%, and a net profit attributable to shareholders of 474 million yuan, up 14.85% year-on-year [1] - The company's liquidity ratios include a current ratio of 0.980 and a quick ratio of 0.808, with a debt-to-asset ratio of 44.36% [1] Group 2 - Lingrui Pharmaceutical has made investments in 14 companies and participated in 5,000 bidding projects [2] - The company holds 287 trademark registrations and 250 patents, along with 355 administrative licenses [2]